AMRX
Price
$7.96
Change
+$0.13 (+1.66%)
Updated
Aug 4 closing price
Capitalization
1.87B
Earnings call today
ZTS
Price
$145.43
Change
-$6.38 (-4.20%)
Updated
Aug 5, 12:28 PM (EDT)
Capitalization
77.48B
Earnings call today
Interact to see
Advertisement

AMRX vs ZTS

Header iconAMRX vs ZTS Comparison
Open Charts AMRX vs ZTSBanner chart's image
Amneal Pharmaceuticals
Price$7.96
Change+$0.13 (+1.66%)
Volume$1.38M
Capitalization1.87B
ZOETIS
Price$145.43
Change-$6.38 (-4.20%)
Volume$2.86K
Capitalization77.48B
AMRX vs ZTS Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. ZTS commentary
Aug 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 05, 2025
Stock price -- (AMRX: $7.96 vs. ZTS: $151.81)
Brand notoriety: AMRX: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 86% vs. ZTS: 196%
Market capitalization -- AMRX: $1.87B vs. ZTS: $77.48B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 6 TA indicator(s) are bullish while ZTS’s TA Score has 6 bullish TA indicator(s).

  • AMRX’s TA Score: 6 bullish, 3 bearish.
  • ZTS’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -2.57% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +0.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.04%. For the same industry, the average monthly price growth was +62.31%, and the average quarterly price growth was +85.86%.

Reported Earning Dates

AMRX is expected to report earnings on Nov 07, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.04% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than ZTS: AMRX (90.00) vs ZTS (32.94). AMRX YTD gains are higher at: 0.505 vs. ZTS (-5.914). ZTS has higher annual earnings (EBITDA): 3.67B vs. AMRX (400M). ZTS has more cash in the bank: 2.04B vs. AMRX (91.5M). AMRX has less debt than ZTS: AMRX (2.75B) vs ZTS (6.76B). ZTS has higher revenues than AMRX: ZTS (8.54B) vs AMRX (2.39B).
AMRXZTSAMRX / ZTS
Capitalization1.87B77.5B2%
EBITDA400M3.67B11%
Gain YTD0.505-5.914-9%
P/E Ratio90.0032.94273%
Revenue2.39B8.54B28%
Total Cash91.5M2.04B4%
Total Debt2.75B6.76B41%
FUNDAMENTALS RATINGS
AMRX vs ZTS: Fundamental Ratings
AMRX
ZTS
OUTLOOK RATING
1..100
6267
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
6083
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6063
P/E GROWTH RATING
1..100
2979
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRX's Valuation (50) in the Pharmaceuticals Major industry is in the same range as ZTS (50) in the Pharmaceuticals Generic industry. This means that AMRX’s stock grew similarly to ZTS’s over the last 12 months.

AMRX's Profit vs Risk Rating (60) in the Pharmaceuticals Major industry is in the same range as ZTS (83) in the Pharmaceuticals Generic industry. This means that AMRX’s stock grew similarly to ZTS’s over the last 12 months.

AMRX's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as ZTS (100) in the Pharmaceuticals Generic industry. This means that AMRX’s stock grew similarly to ZTS’s over the last 12 months.

AMRX's Price Growth Rating (60) in the Pharmaceuticals Major industry is in the same range as ZTS (63) in the Pharmaceuticals Generic industry. This means that AMRX’s stock grew similarly to ZTS’s over the last 12 months.

AMRX's P/E Growth Rating (29) in the Pharmaceuticals Major industry is somewhat better than the same rating for ZTS (79) in the Pharmaceuticals Generic industry. This means that AMRX’s stock grew somewhat faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXZTS
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
59%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
59%
MACD
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
56%
Declines
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 6 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SSO101.272.96
+3.01%
ProShares Ultra S&P500
TMFX20.950.38
+1.87%
Motley Fool Next ETF
PTIN28.680.36
+1.28%
Pacer Trendpilot International ETF
FEBU26.020.26
+1.00%
AllianzIM U.S. Equity Buffer15 UncFebETF
MMU9.920.02
+0.20%
Western Asset Managed Municipals Fund

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+1.73%
PAHC - AMRX
47%
Loosely correlated
+3.94%
HROW - AMRX
46%
Loosely correlated
+7.01%
VTRS - AMRX
45%
Loosely correlated
+1.48%
AMPH - AMRX
40%
Loosely correlated
+0.90%
ZTS - AMRX
39%
Loosely correlated
+3.01%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+3.01%
ELAN - ZTS
48%
Loosely correlated
+2.03%
VTRS - ZTS
44%
Loosely correlated
+1.48%
PAHC - ZTS
41%
Loosely correlated
+3.94%
AMRX - ZTS
39%
Loosely correlated
+1.73%
HLN - ZTS
37%
Loosely correlated
-1.71%
More